Globus Medical (GMED) PT Raised to $64 at Stifel
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mailGet Alerts GMED Hot Sheet
Price: $82.91 +2.03%
Rating Summary:
22 Buy, 8 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 1 | Down: 17 | New: 0
Rating Summary:
22 Buy, 8 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 1 | Down: 17 | New: 0
Join SI Premium – FREE
Stifel analyst Mathew Blackman raised the price target on Globus Medical (NYSE: GMED) to $64.00 (from $61.00) while maintaining a Buy rating.
You May Also Be Interested In
- Raymond James Downgrades First Busey (BUSE) to Market Perform
- Baxter International (BAX) PT Lowered to $25 at Stifel
- APi Group Corporation (APG) PT Raised to $56 at Jefferies
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
